Indoleamine 2,3 dioxygenase and regulation of T cell immunity

Andrew Mellor

Research output: Contribution to journalReview article

104 Citations (Scopus)

Abstract

Regulation of adaptive immune responses is critically important to allow the adaptive immune system to eradicate infections while causing minimal collateral damage to infected tissues, as well as preventing autoimmune disease mediated by self-reactive lymphocytes. Tumors and pathogens that cause persistent infections can subvert immunoregulatory processes to protect themselves from destruction by T cells, to the detriment of patients. A growing body of evidence supports the hypothesis that specialized subsets of dendritic cells expressing indoleamine 2,3 dioxygenase (IDO), which catalyzes oxidative catabolism of tryptophan, play critical roles in regulation of T cell-mediated immune responses. IDO-dependent T cell suppression by dendritic cells suggests that biochemical changes due to tryptophan catabolism have profound effects on T cell proliferation, differentiation, effector functions, and viability. This has critical implications for immunotherapeutic manipulations designed for patients with cancer and chronic infectious diseases. In this review, I focus on dendritic cells that can express IDO, and which acquire potent T cell regulatory functions as a consequence.

Original languageEnglish (US)
Pages (from-to)20-24
Number of pages5
JournalBiochemical and Biophysical Research Communications
Volume338
Issue number1
DOIs
StatePublished - Dec 9 2005

Fingerprint

Indoleamine-Pyrrole 2,3,-Dioxygenase
T-cells
Immunity
Dendritic Cells
T-Lymphocytes
Tryptophan
Adaptive Immunity
Regulatory T-Lymphocytes
Infection
Lymphocytes
Autoimmune Diseases
Immune system
Communicable Diseases
Cell proliferation
Cell Differentiation
Pathogens
Immune System
Neoplasms
Chronic Disease
Cell Proliferation

Keywords

  • Dendritic cells
  • Immunosuppression
  • Indoleamine 2,3 dioxygenase
  • T cells

ASJC Scopus subject areas

  • Biophysics
  • Biochemistry
  • Molecular Biology
  • Cell Biology

Cite this

Indoleamine 2,3 dioxygenase and regulation of T cell immunity. / Mellor, Andrew.

In: Biochemical and Biophysical Research Communications, Vol. 338, No. 1, 09.12.2005, p. 20-24.

Research output: Contribution to journalReview article

@article{db8ac16fca3c40cdb437702e1cb9e2a6,
title = "Indoleamine 2,3 dioxygenase and regulation of T cell immunity",
abstract = "Regulation of adaptive immune responses is critically important to allow the adaptive immune system to eradicate infections while causing minimal collateral damage to infected tissues, as well as preventing autoimmune disease mediated by self-reactive lymphocytes. Tumors and pathogens that cause persistent infections can subvert immunoregulatory processes to protect themselves from destruction by T cells, to the detriment of patients. A growing body of evidence supports the hypothesis that specialized subsets of dendritic cells expressing indoleamine 2,3 dioxygenase (IDO), which catalyzes oxidative catabolism of tryptophan, play critical roles in regulation of T cell-mediated immune responses. IDO-dependent T cell suppression by dendritic cells suggests that biochemical changes due to tryptophan catabolism have profound effects on T cell proliferation, differentiation, effector functions, and viability. This has critical implications for immunotherapeutic manipulations designed for patients with cancer and chronic infectious diseases. In this review, I focus on dendritic cells that can express IDO, and which acquire potent T cell regulatory functions as a consequence.",
keywords = "Dendritic cells, Immunosuppression, Indoleamine 2,3 dioxygenase, T cells",
author = "Andrew Mellor",
year = "2005",
month = "12",
day = "9",
doi = "10.1016/j.bbrc.2005.08.232",
language = "English (US)",
volume = "338",
pages = "20--24",
journal = "Biochemical and Biophysical Research Communications",
issn = "0006-291X",
publisher = "Academic Press Inc.",
number = "1",

}

TY - JOUR

T1 - Indoleamine 2,3 dioxygenase and regulation of T cell immunity

AU - Mellor, Andrew

PY - 2005/12/9

Y1 - 2005/12/9

N2 - Regulation of adaptive immune responses is critically important to allow the adaptive immune system to eradicate infections while causing minimal collateral damage to infected tissues, as well as preventing autoimmune disease mediated by self-reactive lymphocytes. Tumors and pathogens that cause persistent infections can subvert immunoregulatory processes to protect themselves from destruction by T cells, to the detriment of patients. A growing body of evidence supports the hypothesis that specialized subsets of dendritic cells expressing indoleamine 2,3 dioxygenase (IDO), which catalyzes oxidative catabolism of tryptophan, play critical roles in regulation of T cell-mediated immune responses. IDO-dependent T cell suppression by dendritic cells suggests that biochemical changes due to tryptophan catabolism have profound effects on T cell proliferation, differentiation, effector functions, and viability. This has critical implications for immunotherapeutic manipulations designed for patients with cancer and chronic infectious diseases. In this review, I focus on dendritic cells that can express IDO, and which acquire potent T cell regulatory functions as a consequence.

AB - Regulation of adaptive immune responses is critically important to allow the adaptive immune system to eradicate infections while causing minimal collateral damage to infected tissues, as well as preventing autoimmune disease mediated by self-reactive lymphocytes. Tumors and pathogens that cause persistent infections can subvert immunoregulatory processes to protect themselves from destruction by T cells, to the detriment of patients. A growing body of evidence supports the hypothesis that specialized subsets of dendritic cells expressing indoleamine 2,3 dioxygenase (IDO), which catalyzes oxidative catabolism of tryptophan, play critical roles in regulation of T cell-mediated immune responses. IDO-dependent T cell suppression by dendritic cells suggests that biochemical changes due to tryptophan catabolism have profound effects on T cell proliferation, differentiation, effector functions, and viability. This has critical implications for immunotherapeutic manipulations designed for patients with cancer and chronic infectious diseases. In this review, I focus on dendritic cells that can express IDO, and which acquire potent T cell regulatory functions as a consequence.

KW - Dendritic cells

KW - Immunosuppression

KW - Indoleamine 2,3 dioxygenase

KW - T cells

UR - http://www.scopus.com/inward/record.url?scp=27544490285&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=27544490285&partnerID=8YFLogxK

U2 - 10.1016/j.bbrc.2005.08.232

DO - 10.1016/j.bbrc.2005.08.232

M3 - Review article

C2 - 16157293

AN - SCOPUS:27544490285

VL - 338

SP - 20

EP - 24

JO - Biochemical and Biophysical Research Communications

JF - Biochemical and Biophysical Research Communications

SN - 0006-291X

IS - 1

ER -